Antibodies News and Research

RSS

Newcastle scientists develop new technique that revolutionizes cell culture

A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.

28 Nov 2017

Study provides insight into adaptive evolution of common cold viruses

Common cold season is back, which has people wondering why we catch the same virus, year after year. Why don't we ever develop immunity against the common cold? Professor Pierre Talbot at INRS has known about the incredible variability of coronaviruses for some time.

28 Nov 2017

Study unveils new immunotherapeutic target against multiple myeloma

Osaka - In recent decades monoclonal antibody-based treatment of cancer has been established as one of the most successful therapeutic strategies for both solid tumors and blood cancers.

27 Nov 2017

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development.

23 Nov 2017

Research paves way for development of vaccines against mycoplasma bacteria

Mycoplasma bacteria are one of the most common causes of bacterial pneumonia in children. It is still unclear how the disease develops.

21 Nov 2017

Mother's diet can protect nursing newborns against food allergies, research shows

Research published in the Journal of Experimental Medicine today indicates that a mother's diet can protect nursing newborns against food allergies.

20 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

Scientists suggest possibility of naturally acquired immunity against Zika infection

Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

16 Nov 2017

Brazilian Zika epidemic could soon be over, say scientists

In 2016, news about the Zika virus in Brazil made the headlines in Europe for the first time. With approximately 65 million people affected, it is one of the largest epidemics in the last few years.

16 Nov 2017

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help physicians make better treatment choices for patients with gastric and esophageal adenocarcinoma.

15 Nov 2017

Study identifies molecular pathway critical to development of fibrosis

A study led by investigators at Massachusetts General Hospital and University Health Network in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring and excessive tissue deposition that result from abnormal healing responses and can compromise the function of vital organs.

15 Nov 2017

EKF’s PCT LiquiColor assay receives FDA clearance and validation for use on Beckman AU analyzers

EKF, announces that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared with Beckman AU 480, 680 and 5800 clinical chemistry analyzers.

From EKF Diagnostics 15 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

Nanoparticles carrying CRISPR gene editing tools for genetic modifications

Researchers from MIT have now developed nanoparticles that could carry CRISPR genetic editing systems deep within the cells and perform their functions on the DNA. The paper was published in the November issue of Nature Biotechnology.

14 Nov 2017

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Newly published research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease (GvHD), a potentially lethal complication of bone marrow stem cell (BMSC) transplantation.

14 Nov 2017

Dengue immunity can provide protection from subsequent Zika infection

Manifestations of Zika virus (ZIKV) infection differ drastically. Sometimes they are catastrophic, most notably when they cause microcephaly in some babies born to infected mothers.

13 Nov 2017

New rapid and affordable method shows promise for diagnosis of dry eye diseases

UPM researchers have developed an optical biosensor with an easy, fast and affordable method of read-out that allows the in vitro detection of a biological material. The results obtained are promising for the diagnosis of dry eye diseases.

6 Nov 2017

UofL researchers help discover new autoimmune disease that causes kidney failure

Researchers at the University of Louisville were part of a group that discovered an insidious new autoimmune disease that causes kidney failure.

3 Nov 2017

Research reveals presence of potential autoantigen in patients with aggressive kidney disease

New research reveals the presence of abundant levels of a certain protein in the kidneys of patients with fibrillary glomerulonephritis (FGN). In FGN, large amounts of protein become trapped in the millions of filtering units-;or glomeruli-;that make up the kidney.

3 Nov 2017

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models.

2 Nov 2017

Antibodies News and Research

Newcastle scientists develop new technique that revolutionizes cell culture

Study provides insight into adaptive evolution of common cold viruses

Study unveils new immunotherapeutic target against multiple myeloma

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

Research paves way for development of vaccines against mycoplasma bacteria

Mother's diet can protect nursing newborns against food allergies, research shows

FDA approves new drug to treat bleeding in hemophilia A patients

Scientists suggest possibility of naturally acquired immunity against Zika infection

Brazilian Zika epidemic could soon be over, say scientists

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

Study identifies molecular pathway critical to development of fibrosis

EKF’s PCT LiquiColor assay receives FDA clearance and validation for use on Beckman AU analyzers

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

Nanoparticles carrying CRISPR gene editing tools for genetic modifications

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Dengue immunity can provide protection from subsequent Zika infection

New rapid and affordable method shows promise for diagnosis of dry eye diseases

UofL researchers help discover new autoimmune disease that causes kidney failure

Research reveals presence of potential autoantigen in patients with aggressive kidney disease

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

Antibodies eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News